rocuronio b. braun efg 10mg/ml 10 viales 5ml 50mg
rocuronio kabi 10 mg/ml 10 vials 5 ml 50 mg
rocuronio tamarang efg 10mg/ml 10 vials 5ml 50mg
rocuronio tamarang efg 10mg/ml 10 vials 10ml 100mg
rocuronio b. braun efg 10mg/ml 20 vials 5ml 50mg
rocuronio tamarang efg 10mg/ml 10 ampolles 5ml 50mg
esmeron 10 mg/ml 10 viales 10 ml
اوفلوكساسين تيڤع ٢٠٠ ملغ
abic ltd. - ofloxacin 200 mg - tablets - ofloxacin - bacterial infections due to ofloxacin-susceptible microorganisms, such as:- acute, chronic, or recurrent lower respiratory tract infections (bronchitis) pneumonia (not for the treatment of first choice in pnemonia caused by pneumococci). - chronic and recurrent infections of the ear, nose, and throat. ofloxacin is in general not indicated for the treatment of acute tonsillitis caused by betahaemolytic streptococci. - infections of soft tissues and skin. - infections of the bones and joints. - abdominal infections including infections in the pelvis minor and bacterial enteritis. - infections of the kidney, urinary tract, and genital organs, gonorrhoea.prevention of infections due to ofloxacin-susceptible pathogens in patients with a significant reduction in resistance to infections (e.g. in neutropenic state).